Member Exclusive

Therapeutic for Rett syndrome shows success in preclinical mouse models

Scientists at IDIBELL have reported preclinical success as Mecp2 deficiency in a mouse model is partially rescued following treatment with a novel drug candidate.

Go to the profile of Jasmine Harris
May 17, 2018

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.